Reaction Details Report a problem with these data
Target
Arginase-2, mitochondrial
Ligand
BDBM290424
Substrate
n/a
Meas. Tech.
Inhibition Assay
IC50
3000±n/a nM
Citation
 Van Zandt, M; Jagdmann, GE Arginase inhibitors as therapeutics US Patent  US10603330 Publication Date 3/31/2020 
Target
Name:
Arginase-2, mitochondrial
Synonyms:
ARG2 | ARGI2_HUMAN | Arginase II | Kidney-type arginase | Non-hepatic arginase | Type II arginase
Type:
PROTEIN
Mol. Mass.:
38576.93
Organism:
Homo sapiens (Human)
Description:
ChEMBL_978892
Residue:
354
Sequence:
MSLRGSLSRLLQTRVHSILKKSVHSVAVIGAPFSQGQKRKGVEHGPAAIREAGLMKRLSSLGCHLKDFGDLSFTPVPKDDLYNNLIVNPRSVGLANQELAEVVSRAVSDGYSCVTLGGDHSLAIGTISGHARHCPDLCVVWVDAHADINTPLTTSSGNLHGQPVSFLLRELQDKVPQLPGFSWIKPCISSASIVYIGLRDVDPPEHFILKNYDIQYFSMRDIDRLGIQKVMERTFDLLIGKRQRPIHLSFDIDAFDPTLAPATGTPVVGGLTYREGMYIAEEIHNTGLLSALDLVEVNPQLATSEEEAKTTANLAVDVIASSFGQTREGGHIVYDQLPTPSSPDESENQARVRI
  
Inhibitor
Name:
BDBM290424
Synonyms:
(3R,4S)-3-amino-1-(2-(benzylamino)acetyl)-4-(3- boronopropyl)pyrrolidine-3-carboxylic acid | US10098902, Example 60 | US10603330, Example 60 | US11389464, Example 60
Type:
Small organic molecule
Emp. Form.:
C17H26BN3O5
Mol. Mass.:
363.216
SMILES:
N[C@]1(CN(C[C@@H]1CCCB(O)O)C(=O)CNCc1ccccc1)C(O)=O |r|
Structure:
Search PDB for entries with ligand similarity: